Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Lim

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2016
Prevention of thrombosis in antiphospholipid syndromeWendy Lim
Seminars in Thrombosis and Hemostasis|October 10, 2014
Thrombotic risk in the antiphospholipid syndromeWendy Lim
Journal of Thrombosis and Thrombolysis|November 11, 2009
Using low molecular weight heparin in special patient populationsWendy Lim
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 3, 2009
JOE DOUPE LECTURE: Cardiac troponin in the intensive care unitWendy Lim
Hematology. American Society of Hematology. Education Program|December 17, 2009
Antiphospholipid antibody syndromeWendy Lim
Internal and Emergency Medicine|June 20, 2008
Low-molecular-weight heparin in patients with chronic renal insufficiencyWendy Lim
Hematology. American Society of Hematology. Education Program|December 10, 2013
Antiphospholipid syndromeWendy Lim
Current Opinion in Hematology|July 7, 2011
Complement and the antiphospholipid syndromeWendy Lim
Polskie Archiwum Medycyny Wewnetrznej|August 28, 2007
[Fondaparinux--evolution or revolution in anticoagulant care?]Mark Crowther, Wendy Lim
Chest|April 8, 2009
Balancing the risks and benefits of thromboprophylaxis in patients undergoing podiatric surgeryWendy Lim, Cynthia Wu
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Hematology. American Society of Hematology. Education Program|December 4, 2016
Prevention of thrombosis in antiphospholipid syndromeWendy Lim
Seminars in Thrombosis and Hemostasis|October 10, 2014
Thrombotic risk in the antiphospholipid syndromeWendy Lim
Journal of Thrombosis and Thrombolysis|November 11, 2009
Using low molecular weight heparin in special patient populationsWendy Lim
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 3, 2009
JOE DOUPE LECTURE: Cardiac troponin in the intensive care unitWendy Lim
Hematology. American Society of Hematology. Education Program|December 17, 2009
Antiphospholipid antibody syndromeWendy Lim
Internal and Emergency Medicine|June 20, 2008
Low-molecular-weight heparin in patients with chronic renal insufficiencyWendy Lim
Hematology. American Society of Hematology. Education Program|December 10, 2013
Antiphospholipid syndromeWendy Lim
Current Opinion in Hematology|July 7, 2011
Complement and the antiphospholipid syndromeWendy Lim
Polskie Archiwum Medycyny Wewnetrznej|August 28, 2007
[Fondaparinux--evolution or revolution in anticoagulant care?]Mark Crowther, Wendy Lim
Chest|April 8, 2009
Balancing the risks and benefits of thromboprophylaxis in patients undergoing podiatric surgeryWendy Lim, Cynthia Wu
Pageof 11